Sobi Pays $100m Upfront For Selecta Gout Drug

Set To Challenge Horizon’s Krystexxa

 
• By Kevin Grogan
  
Gout
The refractory gout market is worth $1bn in the US alone • Source: Shutterstock

More from Deals

More from Business